Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolism of Clopidogrel”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03806894
What this trial is testing

Clopidogrel Resistance in Stroke Patients From Different Ethnicities

Who this might be right for
Clopidogrel, Poor Metabolism ofIschemic Stroke
Ziv Hospital 300
Not applicableUnknownNCT00004564
What this trial is testing

The Inhibition of Platelet Antiaggregating Activity of Clopidogrel by Atorvastatin Detected by Erythromycin Breath Test: a Metabolic Inhibition of Hepatic Cytochrome P450-3A

Who this might be right for
HypercholesterolemiaThrombosis
National Center for Research Resources (NCRR)
Not applicableLooking for participantsNCT05566301
What this trial is testing

Multicentric Study on Clopidogrel Resistance in DAPT for CAS (MULTI-RESCLOSA)

Who this might be right for
Clopidogrel, Poor Metabolism ofCarotid Stenosis
IRCCS Policlinico S. Donato 1,140
Not applicableStudy completedNCT02624583
What this trial is testing

Effects of RF on Clopidogrel Resistance in Patients at High Cardiovascular Risk

Who this might be right for
Coronary Artery DiseaseDiabetes Mellitus
University of Monastir 98
Post-approval studies (Phase 4)Study completedNCT02983214
What this trial is testing

Diabetic Artery Obstruction: is it Possible to Reduce Ischemic Events With Cilostazol?

Who this might be right for
Ischemic StrokePeripheral Artery DiseaseDiabetes Mellitus, Type 2
University of Ioannina 826
Post-approval studies (Phase 4)Study completedNCT01823510
What this trial is testing

Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients

Who this might be right for
Type-2 Diabetes MellitusCoronary Artery Disease
Juan J Badimon 20
Not applicableUnknownNCT04027712
What this trial is testing

Platelet Reactivity, B-amyloid, MOTS-c and Mortality of Type II Diabetics With CAD

Who this might be right for
DiabetesClopidogrel ResistanceAmyloid+1 more
University of Athens 120
Post-approval studies (Phase 4)UnknownNCT01743014
What this trial is testing

Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy

Who this might be right for
Diabetes Type 2Diabetic NephropathyVascular Disease
AHEPA University Hospital 60
Post-approval studies (Phase 4)UnknownNCT02698618
What this trial is testing

PRotective Effect on the Coronary Microcirculation of Patients With DIabetes by Clopidogrel or Ticagrelor

Who this might be right for
Diabetes Mellitus, Type 2
Fundacion Investigacion Interhospitalaria Cardiovascular 50
Not applicableStudy completedNCT02191358
What this trial is testing

YouScript IMPACT Registry

Who this might be right for
Adverse Drug EventsAdverse Drug ReactionsDrug Interaction Potentiation+10 more
Genelex Corporation 800
Post-approval studies (Phase 4)Study completedNCT01509365
What this trial is testing

Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Body Mass Index ≥ 27

Who this might be right for
Cardiovascular DiseaseOverweight
Les Laboratoires des Médicaments Stériles 116
Not applicableStudy completedNCT04734028
What this trial is testing

PTRG-DES Consortium

Who this might be right for
Coronary Artery DiseaseClopidogrel, Poor Metabolism ofPlatelet Dysfunction+1 more
Gyeongsang National University Hospital 13,160
Early research (Phase 1)Study completedNCT01012219
What this trial is testing

Evaluate the Effects of Laropiprant on the Antiplatelet Effects of Clopidogrel and Aspirin in Combination (MK-0524A-114)(COMPLETED)

Who this might be right for
Primary HypercholesterolemiaMixed Hyperlipidemia
Merck Sharp & Dohme LLC 36
Early research (Phase 1)Study completedNCT01210339
What this trial is testing

An Interaction Study to Evaluate the Effect of Esomeprazole/Acetylsalicylic Acid on the Metabolism and Effect of Clopidogrel

Who this might be right for
Healthy Volunteers
AstraZeneca 58
Not applicableUnknownNCT04654026
What this trial is testing

The Safety and Efficacy of Antiplatelet Therapy in Patients of CAA

Who this might be right for
Cerebral Amyloid Angiopathy
Shenzhen Second People's Hospital 43
Post-approval studies (Phase 4)Study completedNCT01684813
What this trial is testing

VERifynow in DIabetes Non-responsiveness: a Study on Switching From Clopidogrel to Prasugrel

Who this might be right for
Diabetes Mellitus Type IIAcute Coronary Syndrome
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 65
Not applicableStudy completedNCT00298428
What this trial is testing

Biological Efficacy of Clopidogrel After Implantation of Drug-eluting Stents (SPACE)

Who this might be right for
Coronary Artery DiseaseAtherosclerosisDiabetes Mellitus+1 more
Assistance Publique - Hôpitaux de Paris 159
Not applicableStudy completedNCT02707445
What this trial is testing

Genotyping Influences Outcome of Coronary Artery Stenting

Who this might be right for
Myocardial IschemiaCLOPIDOGREL, POOR METABOLISM of (Disorder)
Korea University Anam Hospital 5,000
Post-approval studies (Phase 4)Study completedNCT03188705
What this trial is testing

CES1 Carriers in the PAPI Study

Who this might be right for
Heart DiseasesCoronary DiseaseCoronary Artery Disease+7 more
University of Maryland, Baltimore 6
Large-scale testing (Phase 3)UnknownNCT03062462
What this trial is testing

Half-dose Ticagrelor Overcomes High-dose Clopidogrel in Acute Coronary Syndrome Patients With High On-Clopidogrel Platelet Reactivity

Who this might be right for
Coronary Artery DiseaseClopidogrel, Poor Metabolism of
First Affiliated Hospital of Harbin Medical University 80
Next Page